Infective endocarditis. (Q53905921)

22 May 2018

review article

1 reference

title

Infective endocarditis. (English)

1 reference

22 May 2018

author name string

Philippe Moreillon

series ordinal

1

1 reference

22 May 2018

Yok-Ai Que

series ordinal

2

1 reference

22 May 2018

language of work or name

English

0 references

publication date

1 January 2004

1 reference

22 May 2018

published in

The Lancet

1 reference

22 May 2018

volume

363

1 reference

22 May 2018

issue

9403

1 reference

22 May 2018

page(s)

139-149

1 reference

22 May 2018

Infective endocarditis: an analysis based on strict case definitions

cites work

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

Infective endocarditis at a large community teaching hospital, 1980-1990. A review of 210 episodes.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

Infective endocarditis: review of 135 cases over 9 years

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

Clinical features, site of involvement, bacteriologic findings, and outcome of infective endocarditis in intravenous drug users

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

Changing profile of infective endocarditis: results of a 1-year survey in France

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

A forty-year review of bacterial endocarditis in infancy and childhood

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

Changing patterns and prognosis of infective endocarditis in childhood

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

Infective endocarditis--a prospective study at the end of the twentieth century: new predisposing conditions, new etiologic agents, and still a high mortality

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

Hospitalizations for bacterial endocarditis after initiation of chronic dialysis in the United States

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

Endocarditis due to rare and fastidious bacteria

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

Clinical features of Staphylococcus aureus endocarditis: a 10-year experience in Denmark

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

Infective endocarditis in adults

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

Thirty-Year Incidence of Infective Endocarditis After Surgery for Congenital Heart Defect

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

Mapping of a first locus for autosomal dominant myxomatous mitral-valve prolapse to chromosome 16p11.2-p12.1.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

Natural history of mitral valve prolapse

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

Relationship between severity of mitral regurgitation and prognosis of mitral valve prolapse: echocardiographic follow-up study

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

Prevalence and correlates of mitral valve prolapse in a population-based sample of American Indians: the Strong Heart Study

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

Underlying cardiac lesions in adults with infective endocarditis. The changing spectrum

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

Mechanical or bioprosthetic valves in the elderly: a 20-year comparison

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

Clinical outcome and long-term prognosis of late prosthetic valve endocarditis: a 20-year experience

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

Influence of referral bias on the apparent clinical spectrum of infective endocarditis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

Outbreak of endocarditis caused by Pseudomonas aeruginosa serotype O11 among pentazocine and tripelennamine abusers in Chicago

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

Prospective study of infective endocarditis among injection drug users

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

Nosocomial endocarditis in the intensive care unit: an analysis of 22 cases

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

Infective endocarditis due to Staphylococcus aureus: 59 prospectively identified cases with follow-up

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

Changing patient characteristics and the effect on mortality in endocarditis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

Pathogenesis of streptococcal and staphylococcal endocarditis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

Role of monocytes in experimental Staphylococcus aureus endocarditis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

Comparative adhesion of seven species of streptococci isolated from the blood of patients with sub-acute bacterial endocarditis to fibrin-platelet clots in vitro.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

Structure of the integrin VLA-4 and its cell-cell and cell-matrix adhesion functions

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

Heterologously expressed Staphylococcus aureus fibronectin-binding proteins are sufficient for invasion of host cells

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

Synthesis of staphylococcal virulence factors is controlled by a regulatory RNA molecule

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

Regulation of exoprotein expression in Staphylococcus aureus by a locus (sar) distinct from agr

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

The histopathology of endocardial sclerosis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

Microbial adhesins recognizing extracellular matrix macromolecules

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

Reassessing the role of Staphylococcus aureus clumping factor and fibronectin-binding protein by expression in Lactococcus lactis.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

Study of Staphylococcus aureus pathogenic genes by transfer and expression in the less virulent organism Streptococcus gordonii

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

Membrane permeabilization by thrombin-induced platelet microbicidal protein 1 is modulated by transmembrane voltage polarity and magnitude

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

In vitro resistance to thrombin-induced platelet microbicidal protein in isolates of Staphylococcus aureus from endocarditis patients correlates with an intravascular device source

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

Selective activation of sar promoters with the use of green fluorescent protein transcriptional fusions as the detection system in the rabbit endocarditis model

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

Structure-activity analysis of synthetic autoinducing thiolactone peptides from Staphylococcus aureus responsible for virulence

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

Antibiotic prophylaxis of experimental endocarditis after dental extractions

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

Dental and cardiac risk factors for infective endocarditis. A population-based, case-control study

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

Efficacy of antibiotic prophylaxis for prevention of native-valve endocarditis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

Experimental Escherichia coli endocarditis in rats: roles of serum bactericidal activity and duration of catheter placement

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

Quorum sensing by peptide pheromones and two‐component signal‐transduction systems in Gram‐positive bacteria

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

Formation of Vegetations during Infective Endocarditis Excludes Binding of Bacterial‐Specific Host Antibodies toEnterococcus faecalis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

Critical influence of timing of administration of granulocyte colony-stimulating factor on antibacterial effect in experimental endocarditis due to Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

Antibiotic prophylaxis for infective endocarditis from an international group of experts towards a European consensus. Group of Experts of the International Society for Chemotherapy

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

Prevention of bacterial endocarditis. Recommendations by the American Heart Association

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

Prevention of Infective Endocarditis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

Procedures associated with infective endocarditis in adults. A case control study

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

Evaluation of new clinical criteria for the diagnosis of infective endocarditis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

Native valve infective endocarditis in elderly and younger adult patients: comparison of clinical features and outcomes with use of the Duke criteria and the Duke Endocarditis Database

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

An evaluation of the Duke criteria in 25 pathologically confirmed cases of prosthetic valve endocarditis.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

Evaluation of the Duke criteria in 93 episodes of prosthetic valve endocarditis: could sensitivity be improved?

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

Negative predictive value of the Duke criteria for infective endocarditis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

Value and limitations of the Duke criteria for the diagnosis of infective endocarditis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

An assessment of the usefulness of the Duke criteria for diagnosing active infective endocarditis.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

Diagnostic methods current best practices and guidelines for identification of difficult-to-culture pathogens in infective endocarditis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

Molecular diagnosis of bacterial endocarditis by broad-range PCR amplification and direct sequencing

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

Whipple's disease and "Tropheryma whippelii".

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

Treatment of streptococcal endocarditis with a single daily dose of ceftriaxone and netilmicin for 14 days: a prospective multicenter study

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

Antibiotic treatment of adults with infective endocarditis due to streptococci, enterococci, staphylococci, and HACEK microorganisms. American Heart Association

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

Oral antibiotic treatment of right-sided staphylococcal endocarditis in injection drug users: Prospective randomized comparison with parenteral therapy

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

Outpatient intravenous antibiotic therapy for endocarditis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

Treatment of experimental endocarditis due to erythromycin-susceptible or -resistant methicillin-resistant Staphylococcus aureus with RP 59500

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

Efficacy of levofloxacin in the treatment of experimental endocarditis caused by viridans group streptococci

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

The in-vitro activity of linezolid (U-100766) and tentative breakpoints

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

Emergence, mechanism, and clinical implications of reduced glycopeptide susceptibility in Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

Beta-lactam resistance mechanisms of methicillin-resistant Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

The Impact of Penicillinase on Cefamandole Treatment and Prophylaxis of Experimental Endocarditis Due to Methicillin‐ResistantStaphylococcus aureus

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

BAL9141, a novel extended-spectrum cephalosporin active against methicillin-resistant Staphylococcus aureus in treatment of experimental endocarditis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

Clinical experience with quinupristin-dalfopristin as rescue treatment of critically ill patients infected with methicillin-resistant staphylococci

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

Quinupristin-dalfopristin combined with beta-lactams for treatment of experimental endocarditis due to Staphylococcus aureus constitutively resistant to macrolide-lincosamide-streptogramin B antibiotics

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

Treatment of experimental endocarditis due to methicillin-susceptible or methicillin-resistant Staphylococcus aureus with trimethoprim-sulfamethoxazole and antibiotics that inhibit cell wall synthesis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

In vivo efficacy of continuous infusion versus intermittent dosing of linezolid compared to vancomycin in a methicillin-resistant Staphylococcus aureus rabbit endocarditis model.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

Vancomycin-resistant enterococci

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

Comparison of different beta-lactam-glycopeptide-gentamicin combinations for an experimental endocarditis caused by a highly beta-lactam-resistant and highly glycopeptide-resistant isolate of Enterococcus faecium

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

Successful management of Brucella mellitensis endocarditis with combined medical and surgical approach

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

Treatment of Q fever endocarditis: comparison of 2 regimens containing doxycycline and ofloxacin or hydroxychloroquine

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

Epidemiologic and clinical characteristics of Bartonella quintana and Bartonella henselae endocarditis: a study of 48 patients

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

Whipple's endocarditis: review of the literature and comparisons with Q fever, Bartonella infection, and blood culture-positive endocarditis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

Current best practices and guidelines indications for surgical intervention in infective endocarditis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

Active native valve endocarditis: determinants of operative death and late mortality

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

Surgery for active culture-positive endocarditis: determinants of early and late outcome

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

Medical treatment or surgical intervention? A cooperative retrospective study on infective endocarditis--timing of operation

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

Valve replacement in patients with native valve endocarditis: what really determines operative outcome?

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

Operation for Infective Endocarditis: Results After Implantation of Mechanical Valves

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

Early surgery in infective endocarditis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

Long-term results of surgery for active infective endocarditis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

Vaccination with FimA from Streptococcus parasanguis protects rats from endocarditis caused by other viridans streptococci

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

Extracellular-matrix-binding proteins as targets for the prevention of Staphylococcus aureus infections

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

Vaccination with Staphylococcus aureus fibrinogen binding proteins (FgBPs) reduces colonisation of S. aureus in a mouse mastitis model

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

Vaccination with a recombinant fragment of collagen adhesin provides protection against Staphylococcus aureus-mediated septic death

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

Immunization with fibronectin binding protein from Staphylococcus aureus protects against experimental endocarditis in rats

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

Use of a Staphylococcus aureus conjugate vaccine in patients receiving hemodialysis.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

Anchoring of surface proteins to the cell wall of Staphylococcus aureus. Sortase catalyzed in vitro transpeptidation reaction using LPXTG peptide and NH(2)-Gly(3) substrates.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

Staphylococcus aureus sortase, an enzyme that anchors surface proteins to the cell wall

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

Inactivation of the srtA gene in Streptococcus gordonii inhibits cell wall anchoring of surface proteins and decreases in vitro and in vivo adhesion

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

The sortase SrtA of Listeria monocytogenes is involved in processing of internalin and in virulence

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

Inactivation of the srtA gene in Listeria monocytogenes inhibits anchoring of surface proteins and affects virulence.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

On the role of Staphylococcus aureus sortase and sortase-catalyzed surface protein anchoring in murine septic arthritis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

Sortase, a universal target for therapeutic agents against gram-positive bacteria?

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

Acetylsalicylic acid reduces vegetation bacterial density, hematogenous bacterial dissemination, and frequency of embolic events in experimental Staphylococcus aureus endocarditis through antiplatelet and antibacterial effects

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

Influence of adjunctive ticlopidine on the treatment of experimental Staphylococcus aureus endocarditis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

Beneficial effect of combination antiplatelet therapy on the development of experimental Staphylococcus aureus endocarditis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

The Role of Platelets in Antimicrobial Host Defense

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

Infective Endocarditis Due to Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

Paravalvular leak and other events in silzone-coated mechanical heart valves: a report from AVERT

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

Phage antibacterials make a comeback

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

A bacteriolytic agent that detects and kills Bacillus anthracis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

Bacteriophage therapy. Stalin's forgotten cure.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

Role of transthoracic and transesophageal echocardiography in predicting embolic events in patients with active infective endocarditis involving native cardiac valves

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

Echocardiography predicts embolic events in infective endocarditis.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)15266-X

7 January 2021

10.1016/S0140-6736(03)15266-X

Identifiers

DOI

1 reference

22 May 2018

1 reference

22 May 2018